CompletedNCT00807222
Lisdexamfetamine and sleep in children with ADHD
About this title
Read the official source — NCT00807222Medication studyAges 6–12United States
Understand this study
Who was this study for?
Listed age limits: 6 years to 12 years.
- Listed locations
- Little RockSee all locations and recruitment
Study information
Study start dateApril 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 24
- Sponsor
- Clinical Study Centers, LLC
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 6 Years to 12 Years
- Official registry ID
- NCT00807222
- Official title
Show the full official title
Study of the Effect of Vyvanse (Lisdexamfetamine Dimesylate) on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Little Rock
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Clinical Study Centers, LLC.
Did this study involve medication?
Yes. The study involved medication, including lisdexamfetamine dimesylate.
Who was this study for?
Listed age limits: 6 years to 12 years.
